Beatriz San Martín, Partner, IP and Technology, Protection and Enforcement
I am an intellectual property specialist with a focus on the life sciences sector and emerging/disruptive technologies. Prior to pursuing a legal career, I was a scientist with a degree and a Wellcome Trust PhD and postdoc from the University of Cambridge specialising in genetics, cellular and molecular biology.
I have significant experience litigating before the UK Courts and the Court of Justice of the European Union, having acted in a number of leading reported IP cases involving a range of technologies including medicinal products (small molecules and biologicals), medical devices, mosquito nets, insulation foams, software and medical imaging. I have also assisted on the largest ever confidential information case in England & Wales.
Though my practice centres on dispute resolution, it need not necessarily involve the courts. I counsel on international IP protection and enforcement strategies, IP infringement avoidance, infringement and validity opinions, licensing issues and provide corporate support on transactions with patent issues.
Chambers has ranked me as a leading IP individual who is "much sought after as a patent litigator for her extensive knowledge of pharmaceutical patents and SPCs". Sources describe me as providing "insightful and timely advice" and who "is very strong technically and very good with clients". I have also been selected as a WIPR Leader, a Who's Who Legal Life Sciences expert, am ranked by IAM and am described by the Legal 500 as having IP expertise with "gives the team the x-factor".
I am a member of the Cell & Gene Therapy Advisory Committee and the Engineering Biology Committee of the UK BioIndustry Association and am a committee member at the Intellectual Property Lawyers' Association (IPLA). I am also a member of the Chartered Institute of Patent Attorneys (CIPA), the International Association for the Protection of Intellectual Property (AIPPI), the European Patent Lawyers' Association (EPLAW) and the American Intellectual Property Lawyers' Association (AIPLA).
I regularly contribute articles to professional publications and am on the editorial advisory board of Cell & Gene Therapy Insights. For the past twelve years I have coordinated a series of IP lectures for the University of Cambridge Masters in Bioscience Enterprise and I lecture on the course. My speaking engagements in the past 12 months have included several presentations on the doctrine of equivalents, the status of plausibility in patent law, SPCs, the unitary patent package and the impact of Brexit, the Trade Secrets Directive and legal hurdles relating to CRISPR Cas 9 Cas9 gene editing.
I am bilingual in Spanish and English, with a good understanding of French.